Systemic therapy for advanced thymic epithelial tumors: a narrative review of current evidence and perspectives

Mari Tone, Takayuki Shiroyama · 2026

Read Systemic therapy for advanced thymic epithelial tumors: a narrative review of current evidence and perspectives by Mari Tone, Takayuki Shiroyama (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13346011.txt.

Description

Mari Tone and Takayuki Shiroyama review drug therapy for advanced thymic tumors in a narrative review from 2026. These rare tumors grow in the chest gland called the thymus. When surgery cannot remove them or they return, drug therapy is the main path, but firm proof is hard to build for rare disease.

The review draws on studies found in major databases up to late 2025. It reports results for thymoma and for thymic carcinoma apart, where data allow. Standard drug pairs still play a large role. New targeted drugs and immune drugs are also covered, with notes on dose and side effects. Clinicians get a clear map of choices.

Catalog record

CREATORMari Tone, Takayuki Shiroyama
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13346011

Browse the full library · About the Tower of Babel